Farberg shares key pearls from his session on when to use hedgehog inhibitors at South Beach Symposium 2023.
Hedgehog inhibitors for the treatment of non-melanoma skin cancers such as basal cell carcinoma and cutaneous squamous cell carcinoma are a hot topic in the current dermatology space. At the 2023 South Beach Symposium (SBS) Meeting in Miami Beach, Florida, Aaron Farberg, MD, FAAD, double-board certified dermatologist, Mohs surgeon, and chief medical officer of Bare Dermatology in Dallas, Texas, discusses key pearls from his session “Hedgehog Inhibitors for BCC,” part of the Cutaneous Oncology Symposium. Farberg also shares what he enjoys most about SBS meetings.
Farberg will be presenting at other sessions throughout the week at SBS, including:
Aaron Farberg, MD, FAAD: Hi everyone. My name is Aaron Farberg. I'm a double board-certified dermatologist and Mohs surgeon and chief medical officer at Bare Dermatology in Dallas, Texas, I’m also affiliated with Baylor Scott and White Health System. I'm going to give you some highlights from my talk on hedgehog inhibitors that will be presented at the upcoming South Beach Symposium 2023 in Miami. The first tip is don't be afraid to use hedgehog inhibitors. They are not that difficult to prescribe or manage and can have a huge impact on your practice and patients. I also want you to expand who you might consider using a hedgehog inhibitor for, such as smaller tubers or as a neoadjuvant therapy. Now finally, I want you to consider using alternative dosing with hedgehog inhibitors. In other words, you won't utilize it every single day.
Dermatology Times®: What do you enjoy most about South Beach Symposium?
Farberg: So, what am I looking forward to at the South Beach symposium? Well, the South Beach Symposium is a world-class conference with world-class faculty and attendees and it's in the great city of Miami in February, so I look forward to seeing you all there.
Transcript edited for clarity
Follow along with all of Dermatology Times®’ South Beach Symposium coverage here.